CCA
TWST icon

Catalyst Capital Advisors’s Twist Bioscience TWST Stock Holding History

Catalyst Capital Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-400
Closed -$9K – 477
2019
Q1 		$9K Sell
400
-100
-20% -$2.26K ﹤0.01% 309
2018
Q4 		$12K Buy
+500
New +$11.1K ﹤0.01% 296

Other funds holding TWST

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Catalyst Capital Advisors's TWST Position: Q2 2019 in Review

Catalyst Capital Advisors sold out of Twist Bioscience (TWST) in Q2 2019, closing a stake of 400 shares — an estimated $9K sold.

Catalyst Capital Advisors first reported a position in TWST in Q4 2018 and held it in 2 quarters. The position peaked at $12K in Q4 2018. 85 funds tracked by Wall St. Rank hold TWST as of Q2 2019.

  • Catalyst Capital Advisors reported no remaining Twist Bioscience position as of Q2 2019 after selling out during the quarter.
  • Catalyst Capital Advisors sold 400 Twist Bioscience shares in Q2 2019, an estimated $9K.
  • Catalyst Capital Advisors first reported a position in Twist Bioscience in Q4 2018 and held it in 2 quarters.
  • Catalyst Capital Advisors's Twist Bioscience position peaked at $12K in Q4 2018.
  • 85 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2019.

Based on Catalyst Capital Advisors's 13F filing for Q2 2019, filed 8 Aug 2019.